Burzynski Research Stock Analysis
| BZYR Stock | USD 0.04 0.01 28.57% |
Burzynski Research is fairly valued with Real Value of 0.0336 and Hype Value of 0.04. The main objective of Burzynski Research pink sheet analysis is to determine its intrinsic value, which is an estimate of what Burzynski Research is worth, separate from its market price. There are two main types of Burzynski Research's stock analysis: fundamental analysis and technical analysis.
The Burzynski Research pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
Burzynski |
Burzynski Pink Sheet Analysis Notes
About 81.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.01. Burzynski Research had not issued any dividends in recent years. Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs to treat cancer. Burzynski Research Institute, Inc. was founded in 1977 and is based in Houston, Texas. Burzynski Research is traded on OTC Exchange in the United States.The quote for Burzynski Research is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on Burzynski Research please contact the company at 713 335 5697 or go to https://www.burzynskiclinic.com.Burzynski Research Investment Alerts
| Burzynski Research is way too risky over 90 days horizon | |
| Burzynski Research has some characteristics of a very speculative penny stock | |
| Burzynski Research appears to be risky and price may revert if volatility continues | |
| The company has a current ratio of 0.11, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Burzynski Research until it has trouble settling it off, either with new capital or with free cash flow. So, Burzynski Research's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Burzynski Research sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Burzynski to invest in growth at high rates of return. When we think about Burzynski Research's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (976.66 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Burzynski Research currently holds about 1.27 K in cash with (325.1 K) of positive cash flow from operations. | |
| Roughly 81.0% of the company shares are held by company insiders |
Burzynski Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 7.3 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Burzynski Research's market, we take the total number of its shares issued and multiply it by Burzynski Research's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 28th of November, Burzynski Research shows the Risk Adjusted Performance of 0.0709, downside deviation of 29.52, and Mean Deviation of 7.61. Burzynski Research technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Burzynski Research standard deviation, value at risk, as well as the relationship between the Value At Risk and kurtosis to decide if Burzynski Research is priced correctly, providing market reflects its regular price of 0.035 per share. As Burzynski Research appears to be a penny stock we also recommend to validate its total risk alpha numbers.Burzynski Research Price Movement Analysis
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Burzynski Research middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Burzynski Research. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Burzynski Research Outstanding Bonds
Burzynski Research issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Burzynski Research uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Burzynski bonds can be classified according to their maturity, which is the date when Burzynski Research has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MPLX LP 4875 Corp BondUS55336VAG59 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| International Game Technology Corp BondUS460599AD57 | View |
Burzynski Research Predictive Daily Indicators
Burzynski Research intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Burzynski Research pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Daily Balance Of Power | (9,223,372,036,855) | |||
| Rate Of Daily Change | 0.71 | |||
| Day Median Price | 0.035 | |||
| Day Typical Price | 0.035 | |||
| Price Action Indicator | (0.01) | |||
| Period Momentum Indicator | (0.01) |
Burzynski Research Forecast Models
Burzynski Research's time-series forecasting models are one of many Burzynski Research's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Burzynski Research's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Burzynski Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Burzynski Research prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Burzynski shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Burzynski Research. By using and applying Burzynski Pink Sheet analysis, traders can create a robust methodology for identifying Burzynski entry and exit points for their positions.
Burzynski Research Institute, Inc. engages in the research and development of antineoplaston drugs to treat cancer. Burzynski Research Institute, Inc. was founded in 1977 and is based in Houston, Texas. Burzynski Research is traded on OTC Exchange in the United States.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding Burzynski Research to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Commodity Channel Now
Commodity ChannelUse Commodity Channel Index to analyze current equity momentum |
| All Next | Launch Module |
Additional Tools for Burzynski Pink Sheet Analysis
When running Burzynski Research's price analysis, check to measure Burzynski Research's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Burzynski Research is operating at the current time. Most of Burzynski Research's value examination focuses on studying past and present price action to predict the probability of Burzynski Research's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Burzynski Research's price. Additionally, you may evaluate how the addition of Burzynski Research to your portfolios can decrease your overall portfolio volatility.